Brachytherapy for advanced prostate cancer bleeding | Zendy

Ramesh Thurairaja | Zendy; Richard Pocock | Zendy; Malcolm Crundwell | Zendy; M. STOTT | Zendy; Claire E. Rowlands | Zendy; Rajaguru Srinivasan | Zendy; Denise Sheehan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Brachytherapy for advanced prostate cancer bleeding

Author(s) -

Ramesh Thurairaja,

Richard Pocock,

Malcolm Crundwell,

M. STOTT,

Claire E. Rowlands,

Rajaguru Srinivasan,

Denise Sheehan

Publication year - 2008

Publication title -

prostate cancer and prostatic diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2

H-Index - 64

eISSN - 1476-5608

pISSN - 1365-7852

DOI - 10.1038/pcan.2008.12

Subject(s) - brachytherapy , medicine , prostate cancer , prostate , radiology , urology , cancer , radiation therapy

Advanced prostate cancer patients frequently deal with intractable prostatic bleeding which is a difficult problem to manage. Intraurethral high-dose rate (HDR) brachytherapy may palliate this condition. Advanced prostate cancer patients with intractable prostatic bleeding were offered brachytherapy with Iridium-192 using a Micro-selectron HDR machine. During a 5-year period, analysis was performed in 23 patients with a median age and Gleason score of 78 years and 9, respectively. Following brachytherapy, haematuria resolved in 19 of the 23 patients and was recurrence free at 6 months. Intraurethral HDR brachytherapy is a potentially effective modality for treating haematuria in patients with advanced prostate cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research